TXMD

Healthcare Drug Manufacturers - Specialty & Generic

TherapeuticsMD, Inc.

$2.05

+0.03 +1.49% today

Price History

Not enough data

Key Stats

Market Cap

23.73M

Avg Volume

25,021

EPS

-$0.04

52W High

$2.95

52W Low

$0.99

Div. Yield

0.0%

Valuation

Forward P/E

5.86

P/B Ratio

0.88

P/S Ratio

7.26

EV/EBITDA

-14.68

EV/Revenue

6.15

Margins

Gross Margin 100.0%

Operating Margin (32.2%)

Net Margin (6.6%)

EBITDA Margin (41.9%)

Growth & Returns

Revenue Growth (YoY)

(8.7%)

Earnings Growth (YoY)

(80.6%)

Earnings Growth (QoQ)

(71.9%)

Return on Equity

(1.1%)

Return on Assets

(2.9%)

Liquidity & Leverage

Current Ratio

3.22

Quick Ratio

2.65

Debt / Equity

0.20

Total Cash

9.19M

Total Debt

5.56M

About

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.